Compare IDCC & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDCC | TECH |
|---|---|---|
| Founded | 1972 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 9.2B |
| IPO Year | N/A | 1989 |
| Metric | IDCC | TECH |
|---|---|---|
| Price | $306.66 | $64.58 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | ★ $412.50 | $70.46 |
| AVG Volume (30 Days) | 268.2K | ★ 1.6M |
| Earning Date | 02-05-2026 | 02-04-2026 |
| Dividend Yield | ★ 0.91% | 0.49% |
| EPS Growth | ★ 58.70 | N/A |
| EPS | ★ 14.75 | 0.49 |
| Revenue | $928,587,000.00 | ★ $1,216,732,000.00 |
| Revenue This Year | N/A | $2.33 |
| Revenue Next Year | N/A | $7.05 |
| P/E Ratio | ★ $20.96 | $133.64 |
| Revenue Growth | ★ 28.75 | 3.85 |
| 52 Week Low | $169.58 | $46.01 |
| 52 Week High | $412.60 | $79.28 |
| Indicator | IDCC | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 34.77 | 64.93 |
| Support Level | $295.06 | $58.40 |
| Resistance Level | $336.25 | $66.48 |
| Average True Range (ATR) | 10.55 | 1.59 |
| MACD | -2.17 | 0.78 |
| Stochastic Oscillator | 23.93 | 78.84 |
InterDigital Inc is a research and development company focused on wireless, video, Artificial Intelligence, and related technologies. It designs and develops technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. The majority of revenue is generated from fixed-fee patent license agreements, with a smaller portion coming from variable royalty agreements. Geographically it operates in the United States, China, South Korea, Japan, Taiwan, and Europe, out of which the majority is from China.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.